Mackenzie Financial’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,695
Closed -$11.9K 1626
2023
Q2
$11.9K Hold
1,695
﹤0.01% 1502
2023
Q1
$9.66K Hold
1,695
﹤0.01% 1499
2022
Q4
$8.34K Hold
1,695
﹤0.01% 1418
2022
Q3
$19K Buy
1,695
+803
+90% +$10.1K ﹤0.01% 1408
2022
Q2
$12K Buy
+892
New +$20.9K ﹤0.01% 1453
2020
Q2
Sell
-3,343
Closed -$666K 1156
2020
Q1
$666K Sell
3,343
-1,669
-33% -$365K ﹤0.01% 751
2019
Q4
$1.05M Buy
+5,012
New +$720K ﹤0.01% 728

Other funds holding MTEM

Mackenzie Financial's MTEM Position: Q3 2023 in Review

Mackenzie Financial sold out of Molecular Templates, Inc. (MTEM) in Q3 2023, closing a stake of 1,695 shares — an estimated $11.9K sold.

Mackenzie Financial first reported a position in MTEM in Q4 2019 and held it in 7 quarters. The position peaked at $1.05M in Q4 2019. 30 funds tracked by Wall St. Rank hold MTEM as of Q3 2023.

  • Mackenzie Financial reported no remaining Molecular Templates, Inc. position as of Q3 2023 after selling out during the quarter.
  • Mackenzie Financial sold 1,695 Molecular Templates, Inc. shares in Q3 2023, an estimated $11.9K.
  • Mackenzie Financial first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 7 quarters.
  • Mackenzie Financial's Molecular Templates, Inc. position peaked at $1.05M in Q4 2019.
  • 30 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2023.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.